A tree-based scan statistic for database studies with time-to-event outcomes
Abstract
Tree-based scan statistics (TBSSs) are machine learning methods for disproportionality analyses. They simultaneously scan for thousands of hierarchically related health outcomes to detect potential signals of harm from drugs and vaccines, controlling for multiplicity. TBSSs have been extensively used to mine insurance claims databases to detect potential drug adverse events. Current TBSS implementations do not allow comparative safety evaluations with time-to-event outcomes. Explicitly accounting for event timing in analyses can improve power to detect signals compared to methods that use only event counts. We propose three TBSS methods that explicitly leverage event timing to detect potentially harmful effects of drugs. The first assumes proportional hazard rates for each node of the outcome hierarchy and uses a permutation scheme for inference. The second builds on exponential survival models for the terminal nodes of the hierarchy, assuming constant hazard rates at each node, and uses a parametric bootstrap for inference. The third uses robust asymptotic approximations of the hazard rates in connection with an approximate parametric bootstrap. We compare the proposed methods with standard event count based TBSSs in simulation scenarios. Finally, we present results from a database study comparing two glucose-lowering medications among adults with type 2 diabetes.
Related
- Practical guidance for collecting reproducible time-to-event endpoints in retrospective observational oncology studies.
- tteICE: An R Package for Estimating Treatment Effects on Time-to-Event Outcomes with Intercurrent Events in Two-Arm Trials
- Flexible Estimation of Covariate-Specific Win Ratio for Prioritized Time-to-Event Outcomes
- From Test Performance to Risk-Based Effect Sizes: A Unified Wald-Type Framework to Design Clinical Validation Studies for Binary and Survival Outcomes
- Win-Ratio Regression for Prioritized Composite Outcomes in Observational Studies: Doubly Robust and Efficient Estimation with Future-Score Correction
BibTeX
@misc{russo2026treebased,
title = {{A tree-based scan statistic for database studies with time-to-event outcomes}},
author = {Massimiliano Russo and Georg Hahn and Krista F. Huybrechts and Shirley V. Wang},
howpublished = {arXiv},
year = {2026},
month = sep,
doi = {10.48550/arxiv.2609.38582},
eprint = {2609.38582},
archivePrefix = {arXiv},
url = {https://arxiv.org/abs/2609.38582},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - A tree-based scan statistic for database studies with time-to-event outcomes
AU - Massimiliano Russo
AU - Georg Hahn
AU - Krista F. Huybrechts
AU - Shirley V. Wang
PY - 2026
DA - 2026/09/29
PB - arXiv
DO - 10.48550/arxiv.2609.38582
UR - https://arxiv.org/abs/2609.38582
AB - Tree-based scan statistics (TBSSs) are machine learning methods for disproportionality analyses. They simultaneously scan for thousands of hierarchically related health outcomes to detect potential signals of harm from drugs and vaccines, controlling for multiplicity. TBSSs have been extensively used to mine insurance claims databases to detect potential drug adverse events. Current TBSS implementations do not allow comparative safety evaluations with time-to-event outcomes. Explicitly accounting for event timing in analyses can improve power to detect signals compared to methods that use only event counts. We propose three TBSS methods that explicitly leverage event timing to detect potentially harmful effects of drugs. The first assumes proportional hazard rates for each node of the outcome hierarchy and uses a permutation scheme for inference. The second builds on exponential survival models for the terminal nodes of the hierarchy, assuming constant hazard rates at each node, and uses a parametric bootstrap for inference. The third uses robust asymptotic approximations of the hazard rates in connection with an approximate parametric bootstrap. We compare the proposed methods with standard event count based TBSSs in simulation scenarios. Finally, we present results from a database study comparing two glucose-lowering medications among adults with type 2 diabetes.
ER -